[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Nucleic Acid Modifying Enzymes Market Growth 2024-2030

April 2024 | 107 pages | ID: G18F7D01C266EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Nucleic Acid Modifying Enzymes market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Nucleic Acid Modifying Enzymes Industry Forecast” looks at past sales and reviews total world Nucleic Acid Modifying Enzymes sales in 2023, providing a comprehensive analysis by region and market sector of projected Nucleic Acid Modifying Enzymes sales for 2024 through 2030. With Nucleic Acid Modifying Enzymes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acid Modifying Enzymes industry.

This Insight Report provides a comprehensive analysis of the global Nucleic Acid Modifying Enzymes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nucleic Acid Modifying Enzymes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nucleic Acid Modifying Enzymes market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acid Modifying Enzymes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acid Modifying Enzymes.

United States market for Nucleic Acid Modifying Enzymes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Nucleic Acid Modifying Enzymes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Nucleic Acid Modifying Enzymes is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Nucleic Acid Modifying Enzymes players cover New England Biolabs (NEB), Thermo Fisher Scientific, Promega, Takara Bio and Qiagen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Modifying Enzymes market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
  • Polymerases
  • Ligases
  • Nucleases
  • Reverse Transcriptases
  • Topoisomerases
  • Methyltransferases
  • Helicases
  • Restriction Enzymes
  • Modifying Enzymes
Segmentation by application
  • Biomedical and Clinical Applications
  • Agriculture and Biotechnology
  • Industrial Processes
  • Education and Training
  • Biomedical and Agricultural Research Institutes
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • New England Biolabs (NEB)
  • Thermo Fisher Scientific
  • Promega
  • Takara Bio
  • Qiagen
  • Agilent Technologies
  • Bioline
  • Lucigen
  • Thermo Scientific
  • Epicentre (an Illumina company)
Key Questions Addressed in this Report

What is the 10-year outlook for the global Nucleic Acid Modifying Enzymes market?

What factors are driving Nucleic Acid Modifying Enzymes market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nucleic Acid Modifying Enzymes market opportunities vary by end market size?

How does Nucleic Acid Modifying Enzymes break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nucleic Acid Modifying Enzymes Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Nucleic Acid Modifying Enzymes by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Nucleic Acid Modifying Enzymes by Country/Region, 2019, 2023 & 2030
2.2 Nucleic Acid Modifying Enzymes Segment by Type
  2.2.1 Polymerases
  2.2.2 Ligases
  2.2.3 Nucleases
  2.2.4 Reverse Transcriptases
  2.2.5 Topoisomerases
  2.2.6 Methyltransferases
  2.2.7 Helicases
  2.2.8 Restriction Enzymes
  2.2.9 Modifying Enzymes
2.3 Nucleic Acid Modifying Enzymes Sales by Type
  2.3.1 Global Nucleic Acid Modifying Enzymes Sales Market Share by Type (2019-2024)
  2.3.2 Global Nucleic Acid Modifying Enzymes Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Nucleic Acid Modifying Enzymes Sale Price by Type (2019-2024)
2.4 Nucleic Acid Modifying Enzymes Segment by Application
  2.4.1 Biomedical and Clinical Applications
  2.4.2 Agriculture and Biotechnology
  2.4.3 Industrial Processes
  2.4.4 Education and Training
  2.4.5 Biomedical and Agricultural Research Institutes
  2.4.6 Others
2.5 Nucleic Acid Modifying Enzymes Sales by Application
  2.5.1 Global Nucleic Acid Modifying Enzymes Sale Market Share by Application (2019-2024)
  2.5.2 Global Nucleic Acid Modifying Enzymes Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Nucleic Acid Modifying Enzymes Sale Price by Application (2019-2024)

3 GLOBAL NUCLEIC ACID MODIFYING ENZYMES BY COMPANY

3.1 Global Nucleic Acid Modifying Enzymes Breakdown Data by Company
  3.1.1 Global Nucleic Acid Modifying Enzymes Annual Sales by Company (2019-2024)
  3.1.2 Global Nucleic Acid Modifying Enzymes Sales Market Share by Company (2019-2024)
3.2 Global Nucleic Acid Modifying Enzymes Annual Revenue by Company (2019-2024)
  3.2.1 Global Nucleic Acid Modifying Enzymes Revenue by Company (2019-2024)
  3.2.2 Global Nucleic Acid Modifying Enzymes Revenue Market Share by Company (2019-2024)
3.3 Global Nucleic Acid Modifying Enzymes Sale Price by Company
3.4 Key Manufacturers Nucleic Acid Modifying Enzymes Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nucleic Acid Modifying Enzymes Product Location Distribution
  3.4.2 Players Nucleic Acid Modifying Enzymes Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR NUCLEIC ACID MODIFYING ENZYMES BY GEOGRAPHIC REGION

4.1 World Historic Nucleic Acid Modifying Enzymes Market Size by Geographic Region (2019-2024)
  4.1.1 Global Nucleic Acid Modifying Enzymes Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Nucleic Acid Modifying Enzymes Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nucleic Acid Modifying Enzymes Market Size by Country/Region (2019-2024)
  4.2.1 Global Nucleic Acid Modifying Enzymes Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Nucleic Acid Modifying Enzymes Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nucleic Acid Modifying Enzymes Sales Growth
4.4 APAC Nucleic Acid Modifying Enzymes Sales Growth
4.5 Europe Nucleic Acid Modifying Enzymes Sales Growth
4.6 Middle East & Africa Nucleic Acid Modifying Enzymes Sales Growth

5 AMERICAS

5.1 Americas Nucleic Acid Modifying Enzymes Sales by Country
  5.1.1 Americas Nucleic Acid Modifying Enzymes Sales by Country (2019-2024)
  5.1.2 Americas Nucleic Acid Modifying Enzymes Revenue by Country (2019-2024)
5.2 Americas Nucleic Acid Modifying Enzymes Sales by Type
5.3 Americas Nucleic Acid Modifying Enzymes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nucleic Acid Modifying Enzymes Sales by Region
  6.1.1 APAC Nucleic Acid Modifying Enzymes Sales by Region (2019-2024)
  6.1.2 APAC Nucleic Acid Modifying Enzymes Revenue by Region (2019-2024)
6.2 APAC Nucleic Acid Modifying Enzymes Sales by Type
6.3 APAC Nucleic Acid Modifying Enzymes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nucleic Acid Modifying Enzymes by Country
  7.1.1 Europe Nucleic Acid Modifying Enzymes Sales by Country (2019-2024)
  7.1.2 Europe Nucleic Acid Modifying Enzymes Revenue by Country (2019-2024)
7.2 Europe Nucleic Acid Modifying Enzymes Sales by Type
7.3 Europe Nucleic Acid Modifying Enzymes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nucleic Acid Modifying Enzymes by Country
  8.1.1 Middle East & Africa Nucleic Acid Modifying Enzymes Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Nucleic Acid Modifying Enzymes Revenue by Country (2019-2024)
8.2 Middle East & Africa Nucleic Acid Modifying Enzymes Sales by Type
8.3 Middle East & Africa Nucleic Acid Modifying Enzymes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nucleic Acid Modifying Enzymes
10.3 Manufacturing Process Analysis of Nucleic Acid Modifying Enzymes
10.4 Industry Chain Structure of Nucleic Acid Modifying Enzymes

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nucleic Acid Modifying Enzymes Distributors
11.3 Nucleic Acid Modifying Enzymes Customer

12 WORLD FORECAST REVIEW FOR NUCLEIC ACID MODIFYING ENZYMES BY GEOGRAPHIC REGION

12.1 Global Nucleic Acid Modifying Enzymes Market Size Forecast by Region
  12.1.1 Global Nucleic Acid Modifying Enzymes Forecast by Region (2025-2030)
  12.1.2 Global Nucleic Acid Modifying Enzymes Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nucleic Acid Modifying Enzymes Forecast by Type
12.7 Global Nucleic Acid Modifying Enzymes Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 New England Biolabs (NEB)
  13.1.1 New England Biolabs (NEB) Company Information
  13.1.2 New England Biolabs (NEB) Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
  13.1.3 New England Biolabs (NEB) Nucleic Acid Modifying Enzymes Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 New England Biolabs (NEB) Main Business Overview
  13.1.5 New England Biolabs (NEB) Latest Developments
13.2 Thermo Fisher Scientific
  13.2.1 Thermo Fisher Scientific Company Information
  13.2.2 Thermo Fisher Scientific Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
  13.2.3 Thermo Fisher Scientific Nucleic Acid Modifying Enzymes Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Thermo Fisher Scientific Main Business Overview
  13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Promega
  13.3.1 Promega Company Information
  13.3.2 Promega Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
  13.3.3 Promega Nucleic Acid Modifying Enzymes Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Promega Main Business Overview
  13.3.5 Promega Latest Developments
13.4 Takara Bio
  13.4.1 Takara Bio Company Information
  13.4.2 Takara Bio Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
  13.4.3 Takara Bio Nucleic Acid Modifying Enzymes Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Takara Bio Main Business Overview
  13.4.5 Takara Bio Latest Developments
13.5 Qiagen
  13.5.1 Qiagen Company Information
  13.5.2 Qiagen Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
  13.5.3 Qiagen Nucleic Acid Modifying Enzymes Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Qiagen Main Business Overview
  13.5.5 Qiagen Latest Developments
13.6 Agilent Technologies
  13.6.1 Agilent Technologies Company Information
  13.6.2 Agilent Technologies Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
  13.6.3 Agilent Technologies Nucleic Acid Modifying Enzymes Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Agilent Technologies Main Business Overview
  13.6.5 Agilent Technologies Latest Developments
13.7 Bioline
  13.7.1 Bioline Company Information
  13.7.2 Bioline Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
  13.7.3 Bioline Nucleic Acid Modifying Enzymes Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Bioline Main Business Overview
  13.7.5 Bioline Latest Developments
13.8 Lucigen
  13.8.1 Lucigen Company Information
  13.8.2 Lucigen Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
  13.8.3 Lucigen Nucleic Acid Modifying Enzymes Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Lucigen Main Business Overview
  13.8.5 Lucigen Latest Developments
13.9 Thermo Scientific
  13.9.1 Thermo Scientific Company Information
  13.9.2 Thermo Scientific Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
  13.9.3 Thermo Scientific Nucleic Acid Modifying Enzymes Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Thermo Scientific Main Business Overview
  13.9.5 Thermo Scientific Latest Developments
13.10 Epicentre (an Illumina company)
  13.10.1 Epicentre (an Illumina company) Company Information
  13.10.2 Epicentre (an Illumina company) Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
  13.10.3 Epicentre (an Illumina company) Nucleic Acid Modifying Enzymes Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 Epicentre (an Illumina company) Main Business Overview
  13.10.5 Epicentre (an Illumina company) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Nucleic Acid Modifying Enzymes Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nucleic Acid Modifying Enzymes Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Polymerases
Table 4. Major Players of Ligases
Table 5. Major Players of Nucleases
Table 6. Major Players of Reverse Transcriptases
Table 7. Major Players of Topoisomerases
Table 8. Major Players of Methyltransferases
Table 9. Major Players of Helicases
Table 10. Major Players of Restriction Enzymes
Table 11. Major Players of Modifying Enzymes
Table 12. Global Nucleic Acid Modifying Enzymes Sales by Type (2019-2024) & (Tons)
Table 13. Global Nucleic Acid Modifying Enzymes Sales Market Share by Type (2019-2024)
Table 14. Global Nucleic Acid Modifying Enzymes Revenue by Type (2019-2024) & ($ million)
Table 15. Global Nucleic Acid Modifying Enzymes Revenue Market Share by Type (2019-2024)
Table 16. Global Nucleic Acid Modifying Enzymes Sale Price by Type (2019-2024) & (US$/Ton)
Table 17. Global Nucleic Acid Modifying Enzymes Sales by Application (2019-2024) & (Tons)
Table 18. Global Nucleic Acid Modifying Enzymes Sales Market Share by Application (2019-2024)
Table 19. Global Nucleic Acid Modifying Enzymes Revenue by Application (2019-2024)
Table 20. Global Nucleic Acid Modifying Enzymes Revenue Market Share by Application (2019-2024)
Table 21. Global Nucleic Acid Modifying Enzymes Sale Price by Application (2019-2024) & (US$/Ton)
Table 22. Global Nucleic Acid Modifying Enzymes Sales by Company (2019-2024) & (Tons)
Table 23. Global Nucleic Acid Modifying Enzymes Sales Market Share by Company (2019-2024)
Table 24. Global Nucleic Acid Modifying Enzymes Revenue by Company (2019-2024) ($ Millions)
Table 25. Global Nucleic Acid Modifying Enzymes Revenue Market Share by Company (2019-2024)
Table 26. Global Nucleic Acid Modifying Enzymes Sale Price by Company (2019-2024) & (US$/Ton)
Table 27. Key Manufacturers Nucleic Acid Modifying Enzymes Producing Area Distribution and Sales Area
Table 28. Players Nucleic Acid Modifying Enzymes Products Offered
Table 29. Nucleic Acid Modifying Enzymes Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global Nucleic Acid Modifying Enzymes Sales by Geographic Region (2019-2024) & (Tons)
Table 33. Global Nucleic Acid Modifying Enzymes Sales Market Share Geographic Region (2019-2024)
Table 34. Global Nucleic Acid Modifying Enzymes Revenue by Geographic Region (2019-2024) & ($ millions)
Table 35. Global Nucleic Acid Modifying Enzymes Revenue Market Share by Geographic Region (2019-2024)
Table 36. Global Nucleic Acid Modifying Enzymes Sales by Country/Region (2019-2024) & (Tons)
Table 37. Global Nucleic Acid Modifying Enzymes Sales Market Share by Country/Region (2019-2024)
Table 38. Global Nucleic Acid Modifying Enzymes Revenue by Country/Region (2019-2024) & ($ millions)
Table 39. Global Nucleic Acid Modifying Enzymes Revenue Market Share by Country/Region (2019-2024)
Table 40. Americas Nucleic Acid Modifying Enzymes Sales by Country (2019-2024) & (Tons)
Table 41. Americas Nucleic Acid Modifying Enzymes Sales Market Share by Country (2019-2024)
Table 42. Americas Nucleic Acid Modifying Enzymes Revenue by Country (2019-2024) & ($ Millions)
Table 43. Americas Nucleic Acid Modifying Enzymes Revenue Market Share by Country (2019-2024)
Table 44. Americas Nucleic Acid Modifying Enzymes Sales by Type (2019-2024) & (Tons)
Table 45. Americas Nucleic Acid Modifying Enzymes Sales by Application (2019-2024) & (Tons)
Table 46. APAC Nucleic Acid Modifying Enzymes Sales by Region (2019-2024) & (Tons)
Table 47. APAC Nucleic Acid Modifying Enzymes Sales Market Share by Region (2019-2024)
Table 48. APAC Nucleic Acid Modifying Enzymes Revenue by Region (2019-2024) & ($ Millions)
Table 49. APAC Nucleic Acid Modifying Enzymes Revenue Market Share by Region (2019-2024)
Table 50. APAC Nucleic Acid Modifying Enzymes Sales by Type (2019-2024) & (Tons)
Table 51. APAC Nucleic Acid Modifying Enzymes Sales by Application (2019-2024) & (Tons)
Table 52. Europe Nucleic Acid Modifying Enzymes Sales by Country (2019-2024) & (Tons)
Table 53. Europe Nucleic Acid Modifying Enzymes Sales Market Share by Country (2019-2024)
Table 54. Europe Nucleic Acid Modifying Enzymes Revenue by Country (2019-2024) & ($ Millions)
Table 55. Europe Nucleic Acid Modifying Enzymes Revenue Market Share by Country (2019-2024)
Table 56. Europe Nucleic Acid Modifying Enzymes Sales by Type (2019-2024) & (Tons)
Table 57. Europe Nucleic Acid Modifying Enzymes Sales by Application (2019-2024) & (Tons)
Table 58. Middle East & Africa Nucleic Acid Modifying Enzymes Sales by Country (2019-2024) & (Tons)
Table 59. Middle East & Africa Nucleic Acid Modifying Enzymes Sales Market Share by Country (2019-2024)
Table 60. Middle East & Africa Nucleic Acid Modifying Enzymes Revenue by Country (2019-2024) & ($ Millions)
Table 61. Middle East & Africa Nucleic Acid Modifying Enzymes Revenue Market Share by Country (2019-2024)
Table 62. Middle East & Africa Nucleic Acid Modifying Enzymes Sales by Type (2019-2024) & (Tons)
Table 63. Middle East & Africa Nucleic Acid Modifying Enzymes Sales by Application (2019-2024) & (Tons)
Table 64. Key Market Drivers & Growth Opportunities of Nucleic Acid Modifying Enzymes
Table 65. Key Market Challenges & Risks of Nucleic Acid Modifying Enzymes
Table 66. Key Industry Trends of Nucleic Acid Modifying Enzymes
Table 67. Nucleic Acid Modifying Enzymes Raw Material
Table 68. Key Suppliers of Raw Materials
Table 69. Nucleic Acid Modifying Enzymes Distributors List
Table 70. Nucleic Acid Modifying Enzymes Customer List
Table 71. Global Nucleic Acid Modifying Enzymes Sales Forecast by Region (2025-2030) & (Tons)
Table 72. Global Nucleic Acid Modifying Enzymes Revenue Forecast by Region (2025-2030) & ($ millions)
Table 73. Americas Nucleic Acid Modifying Enzymes Sales Forecast by Country (2025-2030) & (Tons)
Table 74. Americas Nucleic Acid Modifying Enzymes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 75. APAC Nucleic Acid Modifying Enzymes Sales Forecast by Region (2025-2030) & (Tons)
Table 76. APAC Nucleic Acid Modifying Enzymes Revenue Forecast by Region (2025-2030) & ($ millions)
Table 77. Europe Nucleic Acid Modifying Enzymes Sales Forecast by Country (2025-2030) & (Tons)
Table 78. Europe Nucleic Acid Modifying Enzymes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 79. Middle East & Africa Nucleic Acid Modifying Enzymes Sales Forecast by Country (2025-2030) & (Tons)
Table 80. Middle East & Africa Nucleic Acid Modifying Enzymes Revenue Forecast by Country (2025-2030) & ($ millions)
Table 81. Global Nucleic Acid Modifying Enzymes Sales Forecast by Type (2025-2030) & (Tons)
Table 82. Global Nucleic Acid Modifying Enzymes Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 83. Global Nucleic Acid Modifying Enzymes Sales Forecast by Application (2025-2030) & (Tons)
Table 84. Global Nucleic Acid Modifying Enzymes Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 85. New England Biolabs (NEB) Basic Information, Nucleic Acid Modifying Enzymes Manufacturing Base, Sales Area and Its Competitors
Table 86. New England Biolabs (NEB) Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
Table 87. New England Biolabs (NEB) Nucleic Acid Modifying Enzymes Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. New England Biolabs (NEB) Main Business
Table 89. New England Biolabs (NEB) Latest Developments
Table 90. Thermo Fisher Scientific Basic Information, Nucleic Acid Modifying Enzymes Manufacturing Base, Sales Area and Its Competitors
Table 91. Thermo Fisher Scientific Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
Table 92. Thermo Fisher Scientific Nucleic Acid Modifying Enzymes Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Thermo Fisher Scientific Main Business
Table 94. Thermo Fisher Scientific Latest Developments
Table 95. Promega Basic Information, Nucleic Acid Modifying Enzymes Manufacturing Base, Sales Area and Its Competitors
Table 96. Promega Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
Table 97. Promega Nucleic Acid Modifying Enzymes Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Promega Main Business
Table 99. Promega Latest Developments
Table 100. Takara Bio Basic Information, Nucleic Acid Modifying Enzymes Manufacturing Base, Sales Area and Its Competitors
Table 101. Takara Bio Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
Table 102. Takara Bio Nucleic Acid Modifying Enzymes Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. Takara Bio Main Business
Table 104. Takara Bio Latest Developments
Table 105. Qiagen Basic Information, Nucleic Acid Modifying Enzymes Manufacturing Base, Sales Area and Its Competitors
Table 106. Qiagen Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
Table 107. Qiagen Nucleic Acid Modifying Enzymes Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 108. Qiagen Main Business
Table 109. Qiagen Latest Developments
Table 110. Agilent Technologies Basic Information, Nucleic Acid Modifying Enzymes Manufacturing Base, Sales Area and Its Competitors
Table 111. Agilent Technologies Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
Table 112. Agilent Technologies Nucleic Acid Modifying Enzymes Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 113. Agilent Technologies Main Business
Table 114. Agilent Technologies Latest Developments
Table 115. Bioline Basic Information, Nucleic Acid Modifying Enzymes Manufacturing Base, Sales Area and Its Competitors
Table 116. Bioline Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
Table 117. Bioline Nucleic Acid Modifying Enzymes Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 118. Bioline Main Business
Table 119. Bioline Latest Developments
Table 120. Lucigen Basic Information, Nucleic Acid Modifying Enzymes Manufacturing Base, Sales Area and Its Competitors
Table 121. Lucigen Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
Table 122. Lucigen Nucleic Acid Modifying Enzymes Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 123. Lucigen Main Business
Table 124. Lucigen Latest Developments
Table 125. Thermo Scientific Basic Information, Nucleic Acid Modifying Enzymes Manufacturing Base, Sales Area and Its Competitors
Table 126. Thermo Scientific Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
Table 127. Thermo Scientific Nucleic Acid Modifying Enzymes Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 128. Thermo Scientific Main Business
Table 129. Thermo Scientific Latest Developments
Table 130. Epicentre (an Illumina company) Basic Information, Nucleic Acid Modifying Enzymes Manufacturing Base, Sales Area and Its Competitors
Table 131. Epicentre (an Illumina company) Nucleic Acid Modifying Enzymes Product Portfolios and Specifications
Table 132. Epicentre (an Illumina company) Nucleic Acid Modifying Enzymes Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 133. Epicentre (an Illumina company) Main Business
Table 134. Epicentre (an Illumina company) Latest Developments

LIST OF FIGURES

Figure 1. Picture of Nucleic Acid Modifying Enzymes
Figure 2. Nucleic Acid Modifying Enzymes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nucleic Acid Modifying Enzymes Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Nucleic Acid Modifying Enzymes Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Nucleic Acid Modifying Enzymes Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Polymerases
Figure 10. Product Picture of Ligases
Figure 11. Product Picture of Nucleases
Figure 12. Product Picture of Reverse Transcriptases
Figure 13. Product Picture of Topoisomerases
Figure 14. Product Picture of Methyltransferases
Figure 15. Product Picture of Helicases
Figure 16. Product Picture of Restriction Enzymes
Figure 17. Product Picture of Modifying Enzymes
Figure 18. Global Nucleic Acid Modifying Enzymes Sales Market Share by Type in 2023
Figure 19. Global Nucleic Acid Modifying Enzymes Revenue Market Share by Type (2019-2024)
Figure 20. Nucleic Acid Modifying Enzymes Consumed in Biomedical and Clinical Applications
Figure 21. Global Nucleic Acid Modifying Enzymes Market: Biomedical and Clinical Applications (2019-2024) & (Tons)
Figure 22. Nucleic Acid Modifying Enzymes Consumed in Agriculture and Biotechnology
Figure 23. Global Nucleic Acid Modifying Enzymes Market: Agriculture and Biotechnology (2019-2024) & (Tons)
Figure 24. Nucleic Acid Modifying Enzymes Consumed in Industrial Processes
Figure 25. Global Nucleic Acid Modifying Enzymes Market: Industrial Processes (2019-2024) & (Tons)
Figure 26. Nucleic Acid Modifying Enzymes Consumed in Education and Training
Figure 27. Global Nucleic Acid Modifying Enzymes Market: Education and Training (2019-2024) & (Tons)
Figure 28. Nucleic Acid Modifying Enzymes Consumed in Biomedical and Agricultural Research Institutes
Figure 29. Global Nucleic Acid Modifying Enzymes Market: Biomedical and Agricultural Research Institutes (2019-2024) & (Tons)
Figure 30. Nucleic Acid Modifying Enzymes Consumed in Others
Figure 31. Global Nucleic Acid Modifying Enzymes Market: Others (2019-2024) & (Tons)
Figure 32. Global Nucleic Acid Modifying Enzymes Sales Market Share by Application (2023)
Figure 33. Global Nucleic Acid Modifying Enzymes Revenue Market Share by Application in 2023
Figure 34. Nucleic Acid Modifying Enzymes Sales Market by Company in 2023 (Tons)
Figure 35. Global Nucleic Acid Modifying Enzymes Sales Market Share by Company in 2023
Figure 36. Nucleic Acid Modifying Enzymes Revenue Market by Company in 2023 ($ Million)
Figure 37. Global Nucleic Acid Modifying Enzymes Revenue Market Share by Company in 2023
Figure 38. Global Nucleic Acid Modifying Enzymes Sales Market Share by Geographic Region (2019-2024)
Figure 39. Global Nucleic Acid Modifying Enzymes Revenue Market Share by Geographic Region in 2023
Figure 40. Americas Nucleic Acid Modifying Enzymes Sales 2019-2024 (Tons)
Figure 41. Americas Nucleic Acid Modifying Enzymes Revenue 2019-2024 ($ Millions)
Figure 42. APAC Nucleic Acid Modifying Enzymes Sales 2019-2024 (Tons)
Figure 43. APAC Nucleic Acid Modifying Enzymes Revenue 2019-2024 ($ Millions)
Figure 44. Europe Nucleic Acid Modifying Enzymes Sales 2019-2024 (Tons)
Figure 45. Europe Nucleic Acid Modifying Enzymes Revenue 2019-2024 ($ Millions)
Figure 46. Middle East & Africa Nucleic Acid Modifying Enzymes Sales 2019-2024 (Tons)
Figure 47. Middle East & Africa Nucleic Acid Modifying Enzymes Revenue 2019-2024 ($ Millions)
Figure 48. Americas Nucleic Acid Modifying Enzymes Sales Market Share by Country in 2023
Figure 49. Americas Nucleic Acid Modifying Enzymes Revenue Market Share by Country in 2023
Figure 50. Americas Nucleic Acid Modifying Enzymes Sales Market Share by Type (2019-2024)
Figure 51. Americas Nucleic Acid Modifying Enzymes Sales Market Share by Application (2019-2024)
Figure 52. United States Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 53. Canada Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 54. Mexico Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 55. Brazil Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 56. APAC Nucleic Acid Modifying Enzymes Sales Market Share by Region in 2023
Figure 57. APAC Nucleic Acid Modifying Enzymes Revenue Market Share by Regions in 2023
Figure 58. APAC Nucleic Acid Modifying Enzymes Sales Market Share by Type (2019-2024)
Figure 59. APAC Nucleic Acid Modifying Enzymes Sales Market Share by Application (2019-2024)
Figure 60. China Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 61. Japan Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 62. South Korea Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 63. Southeast Asia Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 64. India Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 65. Australia Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 66. China Taiwan Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 67. Europe Nucleic Acid Modifying Enzymes Sales Market Share by Country in 2023
Figure 68. Europe Nucleic Acid Modifying Enzymes Revenue Market Share by Country in 2023
Figure 69. Europe Nucleic Acid Modifying Enzymes Sales Market Share by Type (2019-2024)
Figure 70. Europe Nucleic Acid Modifying Enzymes Sales Market Share by Application (2019-2024)
Figure 71. Germany Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 72. France Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 73. UK Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 74. Italy Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 75. Russia Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 76. Middle East & Africa Nucleic Acid Modifying Enzymes Sales Market Share by Country in 2023
Figure 77. Middle East & Africa Nucleic Acid Modifying Enzymes Revenue Market Share by Country in 2023
Figure 78. Middle East & Africa Nucleic Acid Modifying Enzymes Sales Market Share by Type (2019-2024)
Figure 79. Middle East & Africa Nucleic Acid Modifying Enzymes Sales Market Share by Application (2019-2024)
Figure 80. Egypt Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 81. South Africa Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 82. Israel Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 83. Turkey Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 84. GCC Country Nucleic Acid Modifying Enzymes Revenue Growth 2019-2024 ($ Millions)
Figure 85. Manufacturing Cost Structure Analysis of Nucleic Acid Modifying Enzymes in 2023
Figure 86. Manufacturing Process Analysis of Nucleic Acid Modifying Enzymes
Figure 87. Industry Chain Structure of Nucleic Acid Modifying Enzymes
Figure 88. Channels of Distribution
Figure 89. Global Nucleic Acid Modifying Enzymes Sales Market Forecast by Region (2025-2030)
Figure 90. Global Nucleic Acid Modifying Enzymes Revenue Market Share Forecast by Region (2025-2030)
Figure 91. Global Nucleic Acid Modifying Enzymes Sales Market Share Forecast by Type (2025-2030)
Figure 92. Global Nucleic Acid Modifying Enzymes Revenue Market Share Forecast by Type (2025-2030)
Figure 93. Global Nucleic Acid Modifying Enzymes Sales Market Share Forecast by Application (2025-2030)
Figure 94. Global Nucleic Acid Modifying Enzymes Revenue Market Share Forecast by Application (2025-2030)


More Publications